Search results for: Primary care

Medical Practice Mergers: Being Bigger Has its Advantages

Steven M. Harris, Esq. | May 8, 2012

A merger of medical practices can provide significant and long-term benefits to a rheumatology practice. However, a number of difficult decisions and legal issues must be addressed.

Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

Gretchen Henkel | May 8, 2012

Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

Basics of Biologic Joint Reconstruction

Andreas Gomoll, MD | April 6, 2012

For young patients especially, this can delay knee replacement and provide better outcomes.

Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk

Kathleen Louden | April 6, 2012

Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.

Ethics Forum: The Ethical Pitfalls of Clinical Trials

Robert H. Shmerling, MD | April 6, 2012

Your patient is deciding whether to enroll in a clinical trial at your institution and wants your advice about whether to participate.

Letter: Another Thinking Discipline

Walter Doege, MD | April 6, 2012

I read today the article “How a Rheumatologist Thinks” and I want to say that is one of the most interesting articles I’ve read about clinical medicine.

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD | March 8, 2012

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.

First ARHP ‘Best of the Meeting’ Highlights Sleep Research, Osteoporosis Screening, More

Kathleen Louden | March 8, 2012

“The line between ACR and ARHP sessions has totally blurred,” said Donah Zack Crawford, MA, during the presentation, “Highlights from the 2011 ARHP Sessions,” here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.

Pain is a Tricky Thing to Treat, or Even Evaluate

Simon M. Helfgott, MD | March 8, 2012

Rheumatology is such a gratifying and emotionally rewarding medical specialty. There is no better feeling than helping patients with conditions whose proper diagnosis and management have eluded other practitioners. A patient with diffuse idiopathic skeletal hyperostosis (DISH) presents with pain, and a major clinical tenet of DISH has been its lack of association with pain.

Gout – Rheumatology’s Royal Pain

Staff | March 8, 2012

Gout is a common rheumatic disease often characterized by swelling, redness, and intense pain in the big toe. Once thought to be an exclusive disease of the wealthy who overindulged in food and spirits, gout has become a royal pain for millions of Americans.